Meet Biomay at BIO-Europe 2009 in Vienna (Nov. 2–4, 2009)

At the BIO-Europe partnering conference this year in Vienna, Biomay will address participants interested in the company´s allergy vaccine platform and cGMP services. Biomay´s participants will be Dr. Angela Neubauer, Technology Manager, and Dr. Hans Huber, Head of Production. They will welcome you either in one-to-one partnering meetings or at the booth of the Life Science Austria Vienna Region.

Biomay´s principal goals at BIO-Europe:

1. Angela Neubauer will be the primary contact for companies interested in Biomay´s allergy vaccine candidates. Biomay offers clinical co-development of its comprehensive technology platform and promotes out-licensing models for particular product candidates. The company´s key goal is to find biotech or pharma partners being capable to fully utilize the strengths of Biomay´s allergy vaccine platform. In addition, Biomay will be also interested to talk to financial investors.
Contact: a.neubauer(at)biomay.com

2. Hans Huber will address companies interested in Biomay´s cGMP contract manufacturing services. As a CMO, Biomay offers GMP manufacturing of microbial-based recombinant proteins, allergens, plasmid DNA and minicircles. The company focuses on the manufacturing of small- to medium-size batches for clinical trials (from process development to aseptic filling). Biomay´s approach is to offer an excellent price-performance ratio.
Contact: h.huber(at)biomay.com

We look forward to meeting you at BIO-Europe 2009 !

Visit also:
www.ebdgroup.com/bioeurope/

(Vienna, October 7, 2009)